<DOC>
	<DOCNO>NCT00003625</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining one chemotherapy drug radiation therapy may kill tumor cell . PURPOSE : Phase I trial study effectiveness combination chemotherapy plus radiation therapy treat patient newly diagnose brain stem glioma .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Radiation Therapy Treating Patients With Newly Diagnosed Brain Stem Glioma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine maximum tolerate dose dose limit toxicity vincristine give IV push dose combination continuous infusion cyclosporine oral etoposide concurrent prior radiotherapy child newly diagnose primary intrinsic brain stem glioma . II . Determine incidence severity toxicity vincristine regimen patient . III . Determine safe tolerable dose vincristine condition use phase II study . IV . Seek preliminary evidence antitumor activity set patient . OUTLINE : This dose escalation study vincristine . Patients receive radiotherapy daily 6 week concurrent induction chemotherapy . Induction chemotherapy consist vincristine IV push weekly 6 week , oral etoposide daily day 1-21 29-49 cyclosporine IV 2 hour prior vincristine follow continuous 36 hour infusion . Cohorts 3-6 patient receive escalate dos vincristine . If dose limit toxicity ( DLT ) occur 2 3-6 patient , maximum tolerate dose ( MTD ) exceed precede dose declare MTD . Maintenance therapy consist 6 monthly course cyclosporine IV 36 hour begin day 1 , vincristine IV push day 1 , oral etoposide daily day 1-21 . Patients follow every 6 month 4 year annually thereafter . PROJECTED ACCRUAL : At least 6 patient accrue study rate 12 patient per year .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose diffuse intrinsic brain stem glioma MRI Biopsy neither necessary encourage A least twothirds tumor pons Origin tumor clearly pons Must register within 28 day diagnosis Clinical history le 6 month duration ( cranial nerve deficit , long tract sign , ataxia ) No diffuse leptomeningeal disease PATIENT CHARACTERISTICS : Age : 3 21 Performance status : Karnofsky Lansky 50100 % Life expectancy : At least 6 week Hematopoietic : Absolute neutrophil count least 1,000/mm3 Platelet count least 75,000/mm3 Hepatic : SGPT le 2 time normal Renal : Creatinine normal age OR Creatinine clearance great 70 mL/min PRIOR CONCURRENT THERAPY : Biologic therapy : No prior biologic therapy Chemotherapy : No prior chemotherapy No concurrent chemotherapy Endocrine therapy : Prior steroid stable decrease dos allow Radiotherapy : No prior radiotherapy Surgery : Not specify Other : No concurrent investigational agent</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>untreated childhood brain stem glioma</keyword>
</DOC>